{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:18Z","timestamp":1786988118938,"version":"build-2736575974"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Basque Government\u2019s Department of Education, Universities and Investigation"},{"name":"Spanish Ministry of Economy and Competitiveness"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejpb.2016.10.016","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T14:32:33Z","timestamp":1477319553000},"page":"184-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Applications of lipid nanoparticles in gene therapy"],"prefix":"10.1016","volume":"109","author":[{"given":"Ana","family":"del Pozo-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Solin\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rodr\u00edguez-Gasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.10.016_b0005","series-title":"Guideline on the Quality, Non-Clinical and Clinical Aspects of Gene Therapy Medicinal Products. Draft. EMA\/CAT\/80183\/2014","author":"EMA","year":"2015"},{"key":"10.1016\/j.ejpb.2016.10.016_b0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-62703-260-5_8","article-title":"Programming human dendritic cells with mRNA","volume":"969","author":"Lee","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-62703-260-5_5","article-title":"Nonviral, cationic lipid-mediated delivery of mRNA","volume":"969","author":"Hecker","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0020","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1039\/C4NR01346H","article-title":"Messenger RNA (mRNA) nanoparticle tumour vaccination","volume":"6","author":"Phua","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2016.10.016_b0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/17425247.2014.901308","article-title":"Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines","volume":"11","author":"Deering","year":"2014","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.016_b0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tibtech.2010.07.009","article-title":"RNAi and small interfering RNAs in human disease therapeutic applications","volume":"28","author":"Lares","year":"2010","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0035","first-page":"141","article-title":"Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown","volume":"629","author":"Moore","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.addr.2009.04.004","article-title":"siRNA vs. shRNA: similarities and differences","volume":"61","author":"Rao","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.10.016_b0050","first-page":"105","article-title":"Two decades of clinical gene therapy \u2013 success is finally mounting","volume":"9","author":"Herzog","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.ejpb.2016.10.016_b0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/jgm.1054","article-title":"Mechanism of naked DNA clearance after intravenous injection","volume":"9","author":"Liu","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ejpb.2016.10.016_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2015.07.002","article-title":"Vaginal gene therapy","volume":"92","author":"Rodriguez-Gascon","year":"2015","journal-title":"Adv. Drug Deliv. Rev"},{"key":"10.1016\/j.ejpb.2016.10.016_b0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nbt.1769","article-title":"Gene therapy finds its niche","volume":"29","author":"Sheridan","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0070","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/adma.201502888","article-title":"Combinatorial approach to nanoarchitectonics for nonviral delivery of nucleic acids","volume":"28","author":"Molla","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2016.10.016_b0075","article-title":"Non viral vectors in gene therapy \u2013 an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejpb.2016.10.016_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.adgen.2014.10.003","article-title":"Electroporation-mediated gene delivery","volume":"89","author":"Young","year":"2015","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ejpb.2016.10.016_b0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/hgtb.2014.140","article-title":"Hepatocyte transfection in small pigs after weaning by hydrodynamic intraportal injection of naked dna\/minicircle vectors","volume":"26","author":"Stoller","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ejpb.2016.10.016_b0090","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.6b00030","article-title":"Uptake mechanism and direct translocation of a new CPP for siRNA delivery","author":"Pan","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781118833322.ins1","article-title":"Poly(ester amine) constructed from polyethylenimine and pluronic for gene delivery in vitro and in vivo","volume":"10","author":"Wang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.016_b0100","first-page":"5367","article-title":"Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery","volume":"10","author":"Bose","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.10.016_b0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1166\/jbn.2015.1968","article-title":"Solid lipid nanoparticles as non-viral vectors for gene transfection in a cell model of fabry disease","volume":"11","author":"Ruiz de Garibay","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2014.12.047","article-title":"Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference","volume":"479","author":"Torrecilla","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0115","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.colsurfb.2016.07.026","article-title":"Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES)","volume":"146","author":"Torrecilla","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2016.10.016_b0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2015.09.033","article-title":"Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: in vivo approaches in Rs1h-deficient mouse model","volume":"217","author":"Apaolaza","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2009.10.020","article-title":"Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration","volume":"385","author":"del Pozo-Rodr\u00edguez","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0130","first-page":"1","article-title":"Application of lipid nanoparticles to ocular drug delivery","volume":"24","author":"Battaglia","year":"2016","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.016_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejpb.2016.10.016_b0140","first-page":"1","article-title":"Solid lipid nanoparticles: colloidal carrier systems for drug delivery","volume":"1","author":"Swathi","year":"2010","journal-title":"IJPSR"},{"key":"10.1016\/j.ejpb.2016.10.016_b0145","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"M\u00fcller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.10.016_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2008.09.015","article-title":"Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy","volume":"71","author":"del Pozo-Rodr\u00edguez","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/jop.2012.0128","article-title":"Lipid nanoparticles as drug\/gene delivery systems to the retina","volume":"29","author":"del Pozo-Rodr\u00edguez","year":"2013","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2016.10.016_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0168-3659(01)00506-5","article-title":"Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA","volume":"77","author":"Olbrich","year":"2001","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0165","unstructured":"C. Kneuer, C.-M. Lehr, C. Olbrich, R.H. M\u00fcller, Transfection complexes (Transoplex) having a reduced toxicity, a higher physical stability, and a higher transfection efficiency, and a method for the production thereof. WO02051446, 2002."},{"key":"10.1016\/j.ejpb.2016.10.016_b0170","unstructured":"A. Rodr\u00edguez-Gasc\u00f3n, M.A. Solin\u00eds, A. del Pozo-Rodr\u00edguez, D. Delgado, J.L. Pedraz, Lipid Nanoparticles For Gene Therapy, WO2011015701 (A3), ES2351756 (B1), 2011."},{"key":"10.1016\/j.ejpb.2016.10.016_b0175","unstructured":"A. Rodr\u00edguez-Gasc\u00f3n, M.A. Solin\u00eds, A. del Pozo-Rodr\u00edguez, D. Delgado, E. Fern\u00e1ndez, Lipid Nanoparticles for Treating Ocular Diseases. WO2011015701 (A3), ES2385080 (B1), 2012."},{"key":"10.1016\/j.ejpb.2016.10.016_b0180","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2012.12.014","article-title":"How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances","volume":"166","author":"Rehman","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2007.03.015","article-title":"Solid lipid nanoparticles: formulation factors affecting cell transfection capacity","volume":"339","author":"del Pozo-Rodr\u00edguez","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1088\/0957-4484\/19\/28\/285708","article-title":"Anionic solid lipid nanoparticles supported on protamine\/DNA complexes","volume":"19","author":"Ye","year":"2008","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ejpb.2016.10.016_b0195","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijpharm.2010.03.025","article-title":"Ternary nanoparticles of anionic lipid nanoparticles\/protamine\/DNA for gene delivery","volume":"392","author":"Yuan","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-3659(99)00280-1","article-title":"Effect of DNA\/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA\/cationic liposome complexes and subsequent gene expression","volume":"66","author":"Sakurai","year":"2000","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0210","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10837450.2014.996900","article-title":"Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy","volume":"21","author":"Han","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0215","first-page":"4107","article-title":"Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin","volume":"9","author":"Han","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.10.016_b0220","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/IJN.S77837","article-title":"Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA","volume":"10","author":"Shao","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.10.016_b0225","first-page":"1","article-title":"Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy","volume":"2","author":"Chen","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.016_b0230","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/adhm.201200338","article-title":"Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging","volume":"2","author":"Bae","year":"2013","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejpb.2016.10.016_b0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2003.10.015","article-title":"Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer","volume":"57","author":"Tabatt","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jconrel.2004.02.029","article-title":"Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes","volume":"97","author":"Tabatt","year":"2004","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0245","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1023\/B:PHAM.0000041463.56768.ec","article-title":"Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo","volume":"21","author":"Rudolph","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.10.016_b0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2005.09.003","article-title":"Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands","volume":"62","author":"Pedersen","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0255","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejpb.2007.02.006","article-title":"Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pE-plasmid","volume":"67","author":"Vighi","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.04.023","article-title":"Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells","volume":"360","author":"del Pozo-Rodr\u00edguez","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2008.09.004","article-title":"A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors","volume":"133","author":"del Pozo-Rodr\u00edguez","year":"2009","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0270","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2011.06.005","article-title":"Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway","volume":"79","author":"Delgado","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0275","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jconrel.2010.07.065","article-title":"Design of solid lipid nanoparticles for gene delivery into prostate cancer","volume":"148","author":"de Jesus","year":"2010","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0280","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.drudis.2010.09.429","article-title":"Solid lipid nanoparticles for gene delivery into prostate cancer cells","volume":"15","author":"de Jesus","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2016.10.016_b0285","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2010.01.030","article-title":"PDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles","volume":"389","author":"Vighi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0290","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejpb.2010.07.012","article-title":"Nuclear localization of cationic solid lipid nanoparticles containing protamine as transfection promoter","volume":"76","author":"Vighi","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijpharm.2011.12.052","article-title":"Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice","volume":"425","author":"Delgado","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejps.2013.08.013","article-title":"New gene delivery system based on oligochitosan and solid lipid nanoparticles: \u2019in vitro\u2019 and \u2019in vivo\u2019 evaluation","volume":"50","author":"Delgado","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.016_b0305","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/IJN.S30928","article-title":"Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems","volume":"7","author":"Jiang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.10.016_b0310","first-page":"2513","article-title":"Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection","volume":"7","author":"Wang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.10.016_b0315","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3892\/ijmm.2014.1770","article-title":"Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy","volume":"34","author":"Han","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejpb.2016.10.016_b0320","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jgm.2749","article-title":"Role of endocytic uptake in transfection efficiency of solid lipid nanoparticles-based nonviral vectors","volume":"15","author":"Ruiz de Garibay","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ejpb.2016.10.016_b0325","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3109\/13880209.2013.876655","article-title":"A promising targeted gene delivery system: folate-modified dexamethasone-conjugated solid lipid nanoparticles","volume":"52","author":"Wang","year":"2014","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0330","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1166\/jnn.2015.9002","article-title":"Factorial design and development of solid lipid nanoparticles (SLN) for gene delivery","volume":"15","author":"Radaic","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"24","key":"10.1016\/j.ejpb.2016.10.016_b0335","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s11095-007-9234-3","article-title":"Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection","volume":"2007","author":"Asasutjarit","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.10.016_b0340","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejpb.2007.07.011","article-title":"Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells","volume":"68","author":"Choi","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0345","doi-asserted-by":"crossref","first-page":"320","DOI":"10.18433\/J3R30T","article-title":"Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations","volume":"13","author":"Doroud","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.016_b0350","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection","volume":"153","author":"Doroud","year":"2011","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0355","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/hum.2011.115","article-title":"Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis","volume":"23","author":"Delgado","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejpb.2016.10.016_b0360","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/DDDT.S36131","article-title":"Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy","volume":"6","author":"Ruiz de Garibay","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejpb.2016.10.016_b0365","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/pim.12042","article-title":"Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice","volume":"35","author":"Saljoughian","year":"2013","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0370","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2014.02.038","article-title":"A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases","volume":"465","author":"Apaolaza","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0375","doi-asserted-by":"crossref","first-page":"e0124924","DOI":"10.1371\/journal.pone.0124924","article-title":"STAT3 decoy oligodeoxynucleotides-loaded solid lipid nanoparticles induce cell death and inhibit invasion in ovarian cancer cells","volume":"10","author":"Ma","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2016.10.016_b0380","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biomaterials.2016.03.004","article-title":"Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles","volume":"90","author":"Apaolaza","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.10.016_b0385","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1021\/nn203745n","article-title":"In vivo sustained release of siRNA from solid lipid nanoparticles","volume":"5","author":"Lobovkina","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2016.10.016_b0390","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.biomaterials.2010.12.029","article-title":"Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization","volume":"32","author":"Xue","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.10.016_b0395","series-title":"Novel Gene Therapy Approaches","first-page":"75","article-title":"Extracellular and intracellular barriers to non-viral gene transfer","author":"Gottfried","year":"2013"},{"key":"10.1016\/j.ejpb.2016.10.016_b0400","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1021\/bc0601166","article-title":"Employment of cationic solid-lipid nanoparticles as RNA carriers","volume":"18","author":"Montana","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2016.10.016_b0405","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.08.042","article-title":"Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies","volume":"420","author":"Doktorovova","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/17435889.2.2.169","article-title":"Synthetic delivery systems for intravenous administration of nucleic acids","volume":"2","author":"Schiffelers","year":"2007","journal-title":"Nanomed. \u2013 UK"},{"key":"10.1016\/j.ejpb.2016.10.016_b0415","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/mthe.2000.0142","article-title":"Development of biomaterials for gene therapy","volume":"2","author":"Han","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2016.10.016_b0420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2015.04.011","article-title":"The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs)","volume":"235","author":"Hwang","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejpb.2016.10.016_b0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/17425247.2014.945421","article-title":"Recent advances in characterization of nonviral vectors for delivery of nucleic acids: impact on their biological performance","volume":"12","author":"Oliveira","year":"2015","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.016_b0430","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/mabi.201300302","article-title":"HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery","volume":"13","author":"Almalik","year":"2013","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2016.10.016_b0435","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/anie.200352540","article-title":"Potential peptide carriers: amphipathic proline-rich peptides derived from the n-terminal domain of gamma-zein","volume":"43","author":"Fernandez-Carneado","year":"2004","journal-title":"Angew Chem. Int. Edit."},{"key":"10.1016\/j.ejpb.2016.10.016_b0440","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/mt.2013.54","article-title":"Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis","volume":"21","author":"El-Sayed","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2016.10.016_b0445","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ymthe.2005.03.038","article-title":"Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes","volume":"12","author":"Rejman","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2016.10.016_b0450","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s11095-007-9287-3","article-title":"Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells","volume":"24","author":"van der Aa","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.10.016_b0455","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2011.07.015","article-title":"Protein kinase A inhibition modulates the intracellular routing of gene delivery vehicles in HeLa cells, leading to productive transfection","volume":"156","author":"ur Rehman","year":"2011","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2016.10.016_b0460","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ejmech.2005.07.015","article-title":"Synthesis of acridine-nuclear localization signal (NLS) conjugates and evaluation of their impact on lipoplex and polyplex-based transfection","volume":"40","author":"Boulanger","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2016.10.016_b0465","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/gt.2011.96","article-title":"Transcription factor plasmid binding modulates microtubule interactions and intracellular trafficking during gene transfer","volume":"19","author":"Badding","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejpb.2016.10.016_b0470","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtbi.2005.12.015","article-title":"The probable structure of the protamine\u2013DNA complex","volume":"241","author":"Biegeleisen","year":"2006","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0475","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jcp.20152","article-title":"Steroids dilate nuclear pores imaged with atomic force microscopy","volume":"202","author":"Shahin","year":"2005","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0480","unstructured":"Gene Therapy Clinical Trials Worldwide. Provided by the Journal of Gene Medicine. Jon Wiley and Sons Ltd., 2015; <http:\/\/www.wiley.com\/legacy\/wileychi\/genmed\/clinical\/> (accessed 20 March 2016)."},{"issue":"Pt B","key":"10.1016\/j.ejpb.2016.10.016_b0485","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejpb.2014.12.022","article-title":"Treatment of ocular disorders by gene therapy","volume":"95","author":"Solin\u00eds","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.016_b0490","series-title":"Inherited Chorioretinal Dystrophies","first-page":"383","article-title":"X-Linked retinoschisis","author":"Audo","year":"2014"},{"key":"10.1016\/j.ejpb.2016.10.016_b0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2011.12.002","article-title":"X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms","volume":"31","author":"Molday","year":"2012","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.ejpb.2016.10.016_b0500","doi-asserted-by":"crossref","first-page":"161794","DOI":"10.1155\/2014\/161794","article-title":"Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives","volume":"2014","author":"Torrecilla","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejpb.2016.10.016_b0505","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2008.11.010","article-title":"Treatment failure in hepatitis C: mechanisms of non-response","volume":"50","author":"Tai","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2016.10.016_b0510","unstructured":"HIV\/AIDS Fact sheet No. 360, 2013, <http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en> (accessed 20 March 2016)."},{"key":"10.1016\/j.ejpb.2016.10.016_b0515","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.08.008","article-title":"From rare to common and back again: 60years of lysosomal dysfunction","volume":"117","author":"Coutinho","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejpb.2016.10.016_b0520","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40259-013-0032-7","article-title":"Gene therapy for Fabry disease: a review of the literature","volume":"27","author":"Ruiz de Garibay","year":"2013","journal-title":"BioDrugs"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T20:01:55Z","timestamp":1568491315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116307317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":104,"alternative-id":["S0939641116307317"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of lipid nanoparticles in gene therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}